AP2000001926A0 - Voacamine as anti-malarial agent and anti-malarial agent containing voacamine. - Google Patents

Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.

Info

Publication number
AP2000001926A0
AP2000001926A0 APAP/P/2000/001926A AP2000001926A AP2000001926A0 AP 2000001926 A0 AP2000001926 A0 AP 2000001926A0 AP 2000001926 A AP2000001926 A AP 2000001926A AP 2000001926 A0 AP2000001926 A0 AP 2000001926A0
Authority
AP
ARIPO
Prior art keywords
voacamine
malarial agent
malarial
agent containing
pescheria
Prior art date
Application number
APAP/P/2000/001926A
Other languages
English (en)
Inventor
Silvio Rossi
Motta Guiseppe Bertelli
Original Assignee
Millenia Hope Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millenia Hope Inc filed Critical Millenia Hope Inc
Publication of AP2000001926A0 publication Critical patent/AP2000001926A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
APAP/P/2000/001926A 1998-03-26 1999-03-25 Voacamine as anti-malarial agent and anti-malarial agent containing voacamine. AP2000001926A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98TO000264A ITTO980264A1 (it) 1998-03-26 1998-03-26 Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica
PCT/IB1999/000524 WO1999048501A1 (fr) 1998-03-26 1999-03-25 Voacamine en tant qu'agent anti-paludeen et agent anti-paludeen contenant de la voacamine

Publications (1)

Publication Number Publication Date
AP2000001926A0 true AP2000001926A0 (en) 2000-09-30

Family

ID=11416637

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2000/001926A AP2000001926A0 (en) 1998-03-26 1999-03-25 Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.

Country Status (10)

Country Link
EP (1) EP1067938A1 (it)
JP (1) JP2002507570A (it)
AP (1) AP2000001926A0 (it)
AU (1) AU2742799A (it)
BR (1) BR9909153A (it)
CA (1) CA2325879A1 (it)
IT (1) ITTO980264A1 (it)
OA (1) OA11491A (it)
WO (1) WO1999048501A1 (it)
ZA (1) ZA200006020B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812199A1 (fr) * 2000-07-31 2002-02-01 Maximun Frederic Yanze Nouvelles compositions pharmaceutiques effervescentes contenant la chloroquine
EP1491197A1 (fr) * 2003-06-26 2004-12-29 Bertelli Motta, Guiseppe Composition pharmaceutique à base de voacamine pour la stimulation et modulation du système immunitaire humain
US20070232588A1 (en) * 2004-09-15 2007-10-04 Leonard Stella Anti-parasitic and/or anti-viral and/or anti-microbial compositions
US20070032460A1 (en) * 2005-08-04 2007-02-08 Leonard Stella Use of voacamine and related compounds in the treatment of malaria
WO2007039915A1 (en) 2005-10-04 2007-04-12 The Director General, Defence Research And Development Organisation Anti-malarial compound isolated from gomphostema niveum
EP1958638A1 (en) 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans to increase nail growth rate
US20140303148A1 (en) 2011-11-28 2014-10-09 Industry-Academic Cooperation Foundation, Yonsei University Pharmaceutical compositions for inhibiting angiogenesis comprising plant-derived natural compound
CA2896133A1 (en) 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US12377112B2 (en) 2019-04-17 2025-08-05 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2823204A (en) * 1956-03-30 1958-02-11 Gobey Lab Alkaloids of voacanga

Also Published As

Publication number Publication date
ITTO980264A1 (it) 1999-09-26
JP2002507570A (ja) 2002-03-12
CA2325879A1 (fr) 1999-09-30
WO1999048501A9 (fr) 2000-03-16
BR9909153A (pt) 2000-11-14
OA11491A (en) 2004-05-07
WO1999048501A1 (fr) 1999-09-30
EP1067938A1 (fr) 2001-01-17
AU2742799A (en) 1999-10-18
ZA200006020B (en) 2001-06-25

Similar Documents

Publication Publication Date Title
ZA200300793B (en) Substituted-triazolopyrimidines as anticancer agents.
IL147803A0 (en) 28-epirapalogs
WO2001070275A3 (en) Polyglutamic acid-camptothecin conjugates and methods of preparation
IL143901A0 (en) Use of cyclooxygenase-2- inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
MY135721A (en) Amidino compounds useful as nitric oxide synthase inhibitors
ZA200110173B (en) Safety syringe.
MXPA03002080A (es) Derivados de resorcinol.
WO2002076499A3 (en) Combination treatment of pancreatic cancer
MXPA03004932A (es) 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
MX245674B (es) 11 alfa hidroxilasa y oxidorreductasa de aspergillus ochraceus.
AU4347701A (en) Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
AP2000001926A0 (en) Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.
PL346463A1 (en) Method of obtaining derivatives of resorcinol, method of obtaining novel derivatives of 2-oxazabicyclo[2.2.2.]-octan-5-one, method of obtaining novel derivatives of 1,3-cyclohezandione, method of obtaining novel derivatives of 2-cyclohexanone, novel derivatives of 2-oxazabicyclo[2.2.2.]-octan-5-one, novel derivatives of 1,3-cyclohexanodione, and novel derivatives of 2-cyclohexenonea
CA98129S (en) Storage case
AU2002213882A1 (en) Attenuated hiv strains and use thereof
AU2636602A (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
ZA200203163B (en) Lockable drill steel and chuck assembly.
FI20011649L (fi) Korkeapaineinen, suurnopeuksinen primäärinen ja sekundäärinen jalostus
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
ZA200205439B (en) Herpes virus strains.
MY141606A (en) N-alkoxyalkyl-substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa
ZA997490B (en) High hardness and strength sintered body.
MXPA04002104A (es) Anticuerpos contra caspasa-8, su preparacion y uso.
MY129761A (en) Ortho-phenylphenolate concentrates
MD1473F2 (en) Antiherpetic remedy